Switch View
© Globe Newswire
10.10.2025
ISIN: US0327973006
Anavex Life Sciences Corp
AVXL
LISTED
NASDAQ
Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’
News Preview
Presentation title: “Advancing Alzheimer’s Disease Care: Convenience for Both Patients and Families with Oral Blarcamesine” Presentation title: “Advancing Alzheimer’s Disease Care: Convenience for Both Patients and Families with Oral Blarcamesine”...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US81578P1066
Seer Inc
SEER
LISTED
NASDAQ
Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025
News Preview
Scientific presentations reveal how Seer’s Proteograph Product Suite is a critical component of multi-omic translational studies and enables profiling of protein isoform-specific biomarkers Scientific presentations reveal how Seer’s Proteograph Product Suite is a critical component of multi-omic translational studies and enables profiling of protei...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US67092M2089
Nutriband Inc.
NTRB
LISTED
NASDAQ
Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
News Preview
Brand Institute Partnership...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
10.10.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings
News Preview
MINNEAPOLIS, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today published Inspire V clinical outcomes data from its Singapore clinical...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
10.10.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Stockholder Alert: Robbins LLP Informs aTyr Pharma, Inc. Stockholders that a Class Action Lawsuit was Filed Against the Company
News Preview
SAN DIEGO, Oct. 10, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired aTyr Pharma, Inc. (NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025. aTyr is a clinical stage biotechnology company lever...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: CH0363463438
Idorsia Ltd
IDIA
LISTED
SIX
Idorsia successfully completes an upsized offering of shares – funding the company to overall profitability
News Preview
Ad hoc announcement pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
aTyr Pharma, Inc.'s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman
News Preview
SAN FRANCISCO, Oct. 9, 2025 /PRNewswire/ -- A federal class-action lawsuit has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) following a devastating 83% drop in the biotech company's stock price after its lead drug candidate failed to meet its primary endpoint in a critical Phase 3 trial....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.10.2025
ISIN: CA3499331013
Forte Group Holdings Inc.
FGH
LISTED
CSE
Forte Group Announces Equity Incentive Grants and Warrant Amendments
News Preview
VANCOUVER, BC / ACCESS Newswire / October 10, 2025 / Forte Group Holdings Inc. (CSE:FGH)(OTC:FGHFF)(FSE:7BC0, WKN:A40L1Z)("Forte Group" or the "Company"), a next-generation beverage and nutraceutical company focused on longevity and human performance, announces that it has granted stock options ("Stock Options") and re...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: KYG970081173
WuXi Biologics (Cayman) Inc
2269
LISTED
HKSE
WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year
News Preview
SHANGHAI, Oct. 9, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced it has received the esteemed AAA ESG rating from Morgan Stanley Capital International (MSCI) for the third consecutive year.
This top-...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Savara To Contact Him Directly To Discuss Their Options
If you suffered losses in Savara between March 7, 2024 and May 23, 2025 and would like...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: KR7068270008
Celltrion Inc
68270
LISTED
KSC
Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)
News Preview
EYDENZELT® is approved for the treatment of patients with neovascular (wet) age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), and diabetic retinopathy (DR)
Celltrion plans to enter the U.S. ophthalmology market to meet di...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
10.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Semler Scientific To Contact Him Directly To Discuss Their Options
If you suffered losses in Semler Scientific between March 10, 2021 and April...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options
If you suffered losses in Cytokinetics between December 27, 2023 and May 6, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LFMD SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In LifeMD To Contact Him Directly To Discuss Their Options
If you suffered losses in LifeMD between May 7, 2025 and August 5, 2025 and would like...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Biopharma-Führungskräfte bringen die Zukunft der Biowissenschaften auf dem Veeva Commercial Summit Europe voran
News Preview
Branche trifft sich, um die KI-Innovationen von Veeva zu erkunden und Ideen mit Unternehmen wie Astellas, Bayer AG, Boehringer Ingelheim, LEO Pharma, Moderna und MSD auszutauschen
BARCELONA, Spanien, 10. Oktober 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) ga...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
Aetna achieves over 81% of Medicare Advantage members in 4-Star plans and over 63% in 4.5-Star plans for 2026
News Preview
HARTFORD, Conn., Oct. 9, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), announced today that over 81 percent of its Medicare Advantage (MA) members are in 2026 Medicare Advantage Prescription Drug (MAPD) plans that are rated 4 stars or higher (out of 5 stars) by the Centers for Medicare & Med...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CYTK
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinet...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US03969F1093
Arcus Biosciences Inc
RCUS
LISTED
NYSE
Arcus Biosciences Announces New Employment Inducement Grants
News Preview
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted two new employees options to purchase a total of 60,300 shares of the Co...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US86150R1077
Stoke Therapeutics Inc
STOK
LISTED
NASDAQ
Stoke Therapeutics and Biogen Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
News Preview
Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, and Biogen Inc. (Nasdaq: BIIB) today announced the presentation of longer-term follow-up analyses from the ongoing open-label extension (OLE) studies of zorevunersen that support the poten...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US71742Q1067
Phibro Animal Health Corp
PAHC
LISTED
NASDAQ
Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs
News Preview
Phibro Animal Health Corporation (Nasdaq: PAHC), a global leader in animal health and nutrition, today announced it has entered into a licensing agreement with Lighthouse Pharmaceuticals, Inc. for a novel therapeutic asset targeting periodontal health in companion animals.
This agreement grants Phibro exclusive rights to develop, manufacture, an...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US7170811035
Pfizer Inc
PFE
LISTED
NYSE
Pfizer Declares Fourth-Quarter 2025 Dividend
News Preview
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 fourth-quarter 2025 dividend on the company’s common stock, payable December 1, 2025, to holders of the Common Stock of record at the close of business on November 7, 2025. The fourth-quarter 2025 cash dividend will be the 348th consecutive quarterly dividend paid...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson to Participate in the UBS Global Healthcare Conference
News Preview
Johnson & Johnson (NYSE: JNJ) will present at the UBS Global Healthcare Conference on Tuesday, November 11th, 2025. Management will participate in a Fireside Chat at 11:00 a.m. Eastern Time.
A live audio webcast of the presentation will be accessible through Johnson & Johnson’s Investor Relations website at www.investor.jnj.com. An archi...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2025
News Preview
FRANKLIN LAKES, N.J., Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, November 6, 2025 to discuss the Company's financial results for its fourth quarter...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US98978V1035
Zoetis Inc
ZTS
LISTED
NYSE
Zoetis Declares Fourth Quarter 2025 Dividend
News Preview
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.50 per share for the fourth quarter of 2025. The dividend will be paid on Tuesday, December 2, 2025, to all holders of record of the Company’s common stock as of the close of business on Friday, October 31, 2025.
About Zoetis
As the world’s leading animal health com...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US9286611077
VolitionRX Ltd
VNRX
LISTED
XASE
VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock and Common Stock Warrants
News Preview
HENDERSON, Nev., Oct. 9, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that it is proposing to offer and sell, in an underwritten public offering, shares of its common stock and accompanying common stock purchase...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US4050241003
Haemonetics Corp
HAE
LISTED
NYSE
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025
News Preview
BOSTON, Oct. 9, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, November 6, 2025. The Company will hold a conference call with investors and analysts to discuss results and answer qu...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US88025U1097
10X Genomics Inc
TXG
LISTED
NASDAQ
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
News Preview
PLEASANTON, Calif., Oct. 9, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the third quarter ended September 30, 2025 after market close on Thursday, November 6, 2025. The company will host a public conference call...
Themefolio
Profiler
Peergroup
© Newsfile
09.10.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
News Preview
$4 million upfront with up to additional $12 million of potential aggregate gross proceeds upon the exercise in full of warrantsWhite Bear Lake, Minnesota--(Newsfile Corp. - October 9, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, toda...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the third quarter 2025 after market close on Wednesday, October 29, 2025. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the we...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US1241551027
Butterfly Network Inc
BFLY
LISTED
NYSE
Butterfly Network Appoints John Doherty as Chief Financial Officer
News Preview
Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced the appointment of John Doherty as Executive Vice President, Chief Financial Officer, effective December 8, 2025. Doherty has more than 25 years of global financial leadership e...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead Sciences to Release Third Quarter 2025 Financial Results on Thursday, October 30, 2025
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its third quarter 2025 financial results and guidance will be released on Thursday, October 30, 2025 after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s third quarter 2025 financial results and provide a business upda...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US92764N1028
Vir Biotechnology Inc
VIR
LISTED
NASDAQ
Vir Biotechnology Announces First Patient Dosed in Part 3 of Phase 1 Trial of PSMA-Targeting PRO-XTEN® Dual-Masked T-Cell Engager VIR-5500 in Combination with Androgen Receptor Pathway Inhibitors for the Treatment of Metastatic Prostate Cancer
News Preview
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the first patient has been dosed in Part 3 of the Company’s Phase 1 clinical trial evaluating VIR-5500 in combination with androgen receptor pathway inhibitors (ARPIs). VIR-5500 is an investigational PRO-XTEN® dual-masked T-cell engager (TCE) targeting prostate-specific membrane antigen (P...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US5255582018
LeMaitre Vascular Inc
LMAT
LISTED
NASDAQ
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
News Preview
BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and co...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Molina Healthcare, Inc. ("Molina" or "the Company") (NYSE: MOH) and certain of its officers....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027
News Preview
Company underscores differentiated business model; reiterates confidence in its ability to drive above-market membership growth and increasing Adjusted EBITDA profitability1 through 2027, independent of Star ratings...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US09062X1037
Biogen Inc
BIIB
LISTED
NASDAQ
Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
News Preview
– An analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed continuing improvements in cognition and behavior at 2 years; results contrast with minimal change in natural history –...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
Rosen Law Firm Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation – AGL
News Preview
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.
So What: If you purchased agilon health se...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: GB00BMVP7Y09
Royalty Pharma PLC
RPRX
LISTED
NASDAQ
Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025
News Preview
NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter 2025 financial results on Wednesday, November 5, 2025 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US76200L3096
Rezolute, Inc.
RZLT
LISTED
NASDAQ
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
REDWOOD CITY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that it has granted as of September 30, 2025 equity inducement awards to two new employees. The equity awards were appro...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US68752L1008
OrthoPediatrics Corp
KIDS
LISTED
NASDAQ
OrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue and Revised 2025 Guidance
News Preview
Company to host conference call today, October 9th, 2025, to discuss the financial results and updated outlook Company to host conference call today, October 9th, 2025, to discuss the financial results and updated outlook...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US87990A1060
Tenaya Therapeutics Inc
TNYA
LISTED
NASDAQ
Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Faraz Ali, Tenaya’s Chief Executive Officer, will p...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US8723811084
TELA Bio Inc
TELA
LISTED
NASDAQ
TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran
News Preview
MALVERN, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of Betty Jo Rocchio, DNP, RN, CRNA, CENP, EBP-C, to its Board of Directors, and the departure of Lisa Coller...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US7611521078
Resmed Inc
RMD
LISTED
NYSE
Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025
News Preview
SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2026 on Thursday, October 30, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Othe...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: US67080M1036
Nurix Therapeutics Inc
NRIX
LISTED
NASDAQ
Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
News Preview
Announced clinical development plans for bexobrutideg, including the initiation of pivotal trials in relapsed/refractory CLL in H2 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US1255091092
Cigna Group (The)
CI
LISTED
NYSE
The Cigna Group Foundation Teamed Up with Community Organizations To Enhance 34,000 Lives with Youth Mental Health Support
News Preview
BLOOMFIELD, Conn., Oct. 9, 2025 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), today released its Improving Youth Mental Health 2025 Impact Report, highlighting the transformative effect of its youth mental health initiatives across 10 states. With more than $3 mi...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific Inc. (SMLR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 9, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Semler Scientific Inc. ("Semler" or the "Company") (NASDAQ: SMLR) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Oct. 9, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD).
IF YOU ARE AN INVES...
Themefolio
Profiler
Peergroup
© ActuNews
09.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion geeft een update met betrekking tot de strategie voor investering in digitale activa
News Preview
Leuven, BELGIË, 9 oktober 2025, 18u00 – Oxurion NV (Euronext Brussel: OXUR) kondigt vandaag aan dat de afronding van de nieuwe financiering gericht op investeringen in digitale activa (Bitcoin en Ethereum), waarvan de closing oorspronkelijk gepland was op 25 september 2025, nog in voorbereiding is.
De administratieve en compliance-gerela...
Themefolio
Profiler
Peergroup
© ActuNews
09.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion annonce une mise à jour de sa stratégie d'investissement dans des actifs numériques
News Preview
Louvain, BELGIQUE, 9 octobre 2025, 18h00 - Oxurion NV (Euronext Bruxelles : OXUR), annonce aujourd'hui que la finalisation du nouveau financement visant à investir dans des actifs numériques (Bitcoin et Ethereum), dont le closing avait été annoncé pour le 25 septembre 2025, est toujours en cours.
Les ét...
Themefolio
Profiler
Peergroup
© ActuNews
09.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion provides an update related to its investment strategy in digital assets
News Preview
Leuven, BELGIUM, October 9, 2025, 6:00 PM – Oxurion NV (Euronext Brussels: OXUR) announces today that the completion of the new financing aimed at investing in digital assets (Bitcoin and Ethereum), originally scheduled to close on September 25, 2025, is still in progress.
Administrative and compliance-related procedures (notably KYC/AML chec...
Themefolio
Profiler
Peergroup
© ActuNews
09.10.2025
ISIN: FR0000061129
Boiron SA
BOI
LISTED
EURONEXT
BOIRON : Déclaration des droits de vote au 30 septembre 2025
News Preview
Publication
du nombre d'actions composant le capital et du nombre total de droits de vote
(articles L. 233-8 II du code de commerce et 223-16 du règlement général de l'AMF)
Date d'arrêt des informations
Nombre total d'actions composant le capital
Nombre total de droits de vote...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), have until December 2, 2025 to seek appointment as lead plaintiff of the Molina class action lawsuit. Captioned Hindlemann v. Molina Hea...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Development's portfolio company PharmNovo receives approval to initiate a phase 2a trial of its drug candidate PN6047 in Spain
News Preview
STOCKHOLM, SWEDEN – October 9, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company PharmNovo has received approval from the Spanish regulatory authorities to initiate a phase 2a clinical trial of its drug candidate, PN6047, being developed as a treatment for neuropathic pain. The trial will be conduct...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US00973Y1082
Akero Therapeutics Inc
AKRO
LISTED
NASDAQ
Shareholder Alert: The Ademi Firm investigates whether Akero Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
News Preview
MILWAUKEE, Oct. 9, 2025 /PRNewswire/ -- The Ademi Firm is investigating Akero (NASDAQ: AKRO) for possible breaches of fiduciary duty and other violations of law in its transaction with Novo Nordisk....
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US2036681086
Community Health Systems Inc
CYH
LISTED
NYSE
Community Health Systems to Webcast Third Quarter 2025 Conference Call
News Preview
Community Health Systems, Inc. (NYSE: CYH) today announced that it will webcast its third quarter 2025 conference call.
The Company will issue a press release announcing its results on Thursday, October 23, 2025, after the regular close of trading. The conference call is scheduled to begin at 10:00 a.m. Central Time, 11:00 a.m. Eastern Time, on...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: GB0009223206
Smith & Nephew PLC
SN
LISTED
LSE
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT) code for procedures involving its CARTIHEAL AGILI-C Cartilage Repair Implant, effective January 1, 2027. ...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions
News Preview
TIME Best Inventions honors extraordinary innovations changing lives
DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world's...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US12482W4087
cbdMD Inc
YCBD
LISTED
XASE
cbdMD's Herbal Oasis Expands its Florida Footprint with Bevtalk Distribution Partnership
News Preview
CHARLOTTE, N.C., Oct. 9, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the most trusted and recognized cannabidiol (CBD) brands in the United States with a comprehensive line of domestically produced CBD products and Farm Bill–compliant Delta-9 offerings, today announced that its Herbal Oasis hem...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
ISIN: FR0000121667
EssilorLuxottica SA
EL
LISTED
EURONEXT
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025
News Preview
Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
